MLchartDataset catalogue

Xeloda

Term · Oncology and biomedicine · MLC-T-ONC-009402

A drug used alone or with other drugs to treat certain types of colorectal cancer, breast cancer, esophageal cancer, gastroesophageal junction cancer, stomach cancer, and pancreatic cancer. It is also being studied in the treatment of other types of cancer. Xeloda is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Xeloda is a type of antimetabolite. Also called capecitabine.

Table 1. Record
IdentifierMLC-T-ONC-009402
FieldOncology and biomedicine
Synonymscapecitabine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009402",
  "term": "Xeloda",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat certain types of colorectal cancer, breast cancer, esophageal cancer, gastroesophageal junction cancer, stomach cancer, and pancreatic cancer. It is also being studied in the treatment of other types of cancer. Xeloda is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Xeloda is a type of antimetabolite. Also called capecitabine.",
  "synonyms": [
    "capecitabine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/xeloda/"
}

Record 17,486 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.